Rakovina Therapeutics Unveils Preclinical Data at the AACR - World’s Premier Cancer Research Forum
Rakovina will present two abstracts at the meeting, the first: Discovery of novel PARP1-selective inhibitors for treatment of brain tumors using artificial intelligence , explores the use of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results